Materiały źródłowe

• #1 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  The MenB vaccine helps protect against meningococcal group B bacteria that can cause serious illnesses, including meningitis and sepsis. It’s given to children when they’re 8 weeks, 16 weeks and 1 year old. […] Children are offered 3 doses of the MenB vaccine as part of the NHS vaccination schedule. […] It’s best to have the MenB vaccines on time so children are protected when they’re most at risk of getting MenB illnesses. […] If your child has missed any of their MenB vaccines, contact their GP surgery. They can still have the MenB vaccine up to the age of 2. […] Your child can have the MenB vaccine if they’re unwell but they do not have a high temperature. […] If your child has a high temperature, wait until they’re feeling better before having the vaccine. […] Your GP surgery will usually contact you about your child’s MenB vaccinations.

• #2 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  The meningitis B (MenB) vaccine helps protect against meningitis and septicaemia (blood poisoning) caused by meningococcal bacteria B. […] MenB infection is most common in babies and young children. This is because their immune systems arent yet fully developed to fight off infection. The highest number of cases are in babies around 5 months of age. This is why the first immunisations are offered to babies younger than this and have to be given at 2 and 4 months of age. […] The MenB vaccine is routinely offered to all babies at 8, 16 weeks, and 12 to 13 months. […] The MenB vaccine has been part of the routine childhood immunisation programme in Scotland since 1 September 2015. Your local NHS immunisation team will send you an appointment to bring your child in for their routine childhood immunisations.

• #3 MenB vaccine – Essential Parent

  https://hospital.essentialparent.com/lesson/menb-vaccine/?continuity=19398

  The MenB vaccine helps protect against meningococcal group B bacteria that can cause serious illnesses, including meningitis and sepsis. It’s given to children when they’re 8 weeks, 16 weeks and 1 year old. […] Please click the link for information about The MenB vaccine. This helps protect children against bacterial infections caused by meningococcal group B bacteria (MenB). […] MenB can cause serious illnesses, including: meningitis (an infection in the brain and spinal cord) septicaemia (blood poisoning) sepsis (a life-threatening reaction to an infection).

• #4 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Meningococcal vaccine is an active immunizing agent used to prevent infection caused by certain groups of meningococcal bacteria (Neisseria meningitides). The vaccine works by causing your body to produce its own protection (antibodies) against the disease. […] This vaccine is to be given only by or under the supervision of your doctor. […] A nurse or other trained health professional will give this vaccine to you or your child. It is given as a shot under your skin or into one of your muscles. […] Bexsero and Trumenba: An injection is given into a muscle. It is very important for you or your child to receive all of the shots for the vaccine. […] Be sure to notify your doctor of any side effects that occur after you receive this vaccine. […] This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention.

• #5 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  The meningitis B (MenB) vaccine helps protect against meningitis and septicaemia (blood poisoning) caused by meningococcal bacteria B. […] MenB infection is most common in babies and young children. This is because their immune systems arent yet fully developed to fight off infection. The highest number of cases are in babies around 5 months of age. This is why the first immunisations are offered to babies younger than this and have to be given at 2 and 4 months of age. […] The MenB vaccine is routinely offered to all babies at 8, 16 weeks, and 12 to 13 months. […] The MenB vaccine has been part of the routine childhood immunisation programme in Scotland since 1 September 2015. Your local NHS immunisation team will send you an appointment to bring your child in for their routine childhood immunisations.

• #6 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Talk with your health care provider […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. […] Meningococcal B vaccination should be postponed for pregnant women unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks.

• #7 Serogroup B Meningococcal Vaccine (MenB) – What You Need to Know – UF Health

  https://ufhealth.org/conditions-and-treatments/serogroup-b-meningococcal-vaccine-menb-what-you-need-to-know

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: People at risk because of a serogroup B meningococcal disease outbreak, Anyone whose spleen is damaged or has been removed, including people with sickle cell disease, Anyone with a rare immune system condition called „complement component deficiency,” Anyone taking a type of drug called a „complement inhibitor,” such as eculizumab (also called Soliris) or ravulizumab (also called Ultomiris), Microbiologists who routinely work with isolates of N. meningitidis.

• #8

  https://www.meningitis.org/meningitis/vaccine-information/meningococcal-group-b-vaccine

  Meningococcal vaccines protect against disease caused by meningococcal bacteria. […] The vaccines that protect against meningococcal group B (MenB) are protein vaccines. These vaccines contain proteins found on the surface of the bacteria. […] The MenB vaccine provides protection against meningococcal disease, but doesn’t stop you from carrying the bacteria. […] In the UK, it’s recommended to give infants paracetamol soon after the MenB vaccine. This reduces the risk of fever and other side effects. […] Vaccination against meningococcal meningitis is also recommended if you’re travelling to areas at risk. […] Vaccination with conjugate meningococcal vaccines also protects the wider population from meningococcal disease. […] Vaccination is the best way to protect against it.

• #9 Bacterial Meningitis – Texas Higher Education Coordinating Board

  https://www.highered.texas.gov/bacterial-meningitis/

  The meningitis college entry requirement of the Texas Administrative Code states that students must receive a bacterial meningitis vaccination. […] Recently two additional vaccines became available that offer protection from strains of meningococcal serogroup B, commonly known as MenB. […] The CDC Advisory Committee on Immunization Practices (ACIP) recommends MenB vaccinations for certain at risk populations. […] Students should consult a physician or medical practitioner to determine the optimum vaccination protocol for their individual needs. […] It is important to note that vaccinations for MenACWY and MenB are not interchangeable. MenB vaccines do not provide protection for MenACWY strains, and MenACWY vaccines do not provide protection for MenB strains.

• #10 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Talk with your health care provider […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. […] Meningococcal B vaccination should be postponed for pregnant women unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks.

• #11 Serogroup B Meningococcal Vaccine (MenB) – What You Need to Know – UF Health

  https://ufhealth.org/conditions-and-treatments/serogroup-b-meningococcal-vaccine-menb-what-you-need-to-know

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: People at risk because of a serogroup B meningococcal disease outbreak, Anyone whose spleen is damaged or has been removed, including people with sickle cell disease, Anyone with a rare immune system condition called „complement component deficiency,” Anyone taking a type of drug called a „complement inhibitor,” such as eculizumab (also called Soliris) or ravulizumab (also called Ultomiris), Microbiologists who routinely work with isolates of N. meningitidis.

• #12 Serogroup B Meningococcal Vaccine (MenB) – Metro Family Physicians Medical Group

  https://metrofamilyphysicians.com/patient-information/health-library?DOCHWID=a615045

  Serogroup B Meningococcal Vaccine (MenB) […] Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] These vaccines may also be given to anyone 16 through 23 years old to provide short-term protection against most strains of serogroup B meningococcal disease, based on discussions between the patient and health care provider. The preferred age for vaccination is 16 through 18 years. […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit.

• #13 Serogroup B Meningococcal Vaccine (MenB) – Metro Family Physicians Medical Group

  https://metrofamilyphysicians.com/patient-information/health-library?DOCHWID=a615045

  Serogroup B Meningococcal Vaccine (MenB) […] Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] These vaccines may also be given to anyone 16 through 23 years old to provide short-term protection against most strains of serogroup B meningococcal disease, based on discussions between the patient and health care provider. The preferred age for vaccination is 16 through 18 years. […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit.

• #14 FAQ — American Society for Meningitis Prevention

  https://meningitisprevention.org/faq

  The CDC recommends meningococcal vaccination for all adolescents. […] Teens and young adults (16 through 23 years old) may also get a MenB vaccine (2-dose series), preferably at 16 through 18 years old. […] People 10 years or older at increased risk for meningococcal disease should also receive the MenB vaccine. […] The CDCs Advisory Committee on Immunization Practices (ACIP) recommends the MenB vaccine for healthy 16-23-year-olds on the basis of shared clinical decision-making. […] For people aged 10 years and older at increased risk of Meningitis B, the ACIP recommends that 3 doses of Trumenba or Bexsero be administered at 0, 12, and 6 months. […] Some providers recommend that 16-year-olds receive the first dose of the MenB vaccine at the same time that they receive the second dose of the MenACWY vaccine.

• #15 Meningococcal Vaccine Recommendations | Meningococcal | CDC

  https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html

  Both MenB vaccine products require more than 1 dose for maximum protection. Individuals must receive the same vaccine product for all doses. […] CDC recommends a shared clinical decision-making process to decide if MenB vaccination is appropriate for individual adolescents or young adults. […] Administer 2 doses, 6 months apart, to those who want MenB vaccination. […] The preferred age (16 through 18 years) maximizes protection during the ages of highest risk. […] Healthcare providers hopefully will see college-bound adolescents during a pre-college visit. If so, this visit provides an opportunity to initiate the MenB vaccine series for those who choose to receive it. […] People desiring more rapid protection against serogroup B (e.g., students with less than 6 months before college entry) may receive a 3-dose series (0, 12, 6 months) to optimize rapid protection.

• #16 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  The meningitis B (MenB) vaccine helps protect against meningitis and septicaemia (blood poisoning) caused by meningococcal bacteria B. […] MenB infection is most common in babies and young children. This is because their immune systems arent yet fully developed to fight off infection. The highest number of cases are in babies around 5 months of age. This is why the first immunisations are offered to babies younger than this and have to be given at 2 and 4 months of age. […] The MenB vaccine is routinely offered to all babies at 8, 16 weeks, and 12 to 13 months. […] The MenB vaccine has been part of the routine childhood immunisation programme in Scotland since 1 September 2015. Your local NHS immunisation team will send you an appointment to bring your child in for their routine childhood immunisations.

• #17 MenB Vaccine (Meningococcal B Vaccine) | Vaccine Knowledge Project

  https://vaccineknowledge.ox.ac.uk/menb-vaccine

  Meningococcal disease is caused by the bacterium Neisseria meningitidis. It causes a range of serious, life-threatening diseases including septicaemia (blood poisoning) and meningitis (an infection of the protective covering of the brain and spinal cord). […] The MenB vaccine protects against infection by group B meningococcal bacteria. […] In the UK it is recommended that babies receive one dose of the MenB vaccine at 8 weeks, 16 weeks, and one year of age. […] The JCVI also advise that the MenB vaccine should be offered through sexual health services to those who are at increased risk of infection with bacterial sexually transmitted infections. […] Like all vaccines, the MenB vaccine can cause side effects, although not everybody gets them. […] If you are concerned about any reactions that occur after vaccination, consult your doctor.

• #18 Meningococcal B

  https://www.hse.ie/eng/health/immunisation/pubinfo/pcischedule/vpds/menb/

  Meningococcal B disease is prevented by vaccination. […] All children are offered MenB vaccine at 2 and 4 months of age with a booster dose of MenB vaccine given at 12 months. […] Children under 1 year of age are most at risk of getting meningococcal B infection and should be vaccinated. […] The MenB vaccine was introduced in Ireland for all children born on or after 1 October 2016 because children under one year are at the highest risk of meningococcal B disease. […] Any child who has missed a dose of MenB vaccine can still get it from their GP up to the age of 2 years. […] Only meningococcal B infection is prevented by the MenB vaccine. Other types of meningococcal infection are not covered by this vaccine. […] After getting the vaccine, your child may have discomfort, redness or swelling around the area where the injection was given. They may be irritable and have a fever. […] Of the children who are immunised: 1 in 2 will have a fever. […] MenB vaccine has been shown to very effective and safe, providing 88% protection against MenB bacteria types.

• #19 Meningococcal Disease and the Men B Vaccine | AAFP

  https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/meningococcal-disease-vaccine.html

  A serogroup B meningococcal (Men B) vaccine series may be administered to adolescents and young adults 16 through 23 years of age to provide short term protection against most strains of serogroup B meningococcal disease. The preferred age for Men B vaccination is 16 through 18 years of age. […] The ACIP recommends routinely administering Men B vaccines among certain individuals 10 years or older who are at increased risk for serogroup B meningococcal disease. This includes those individuals with complement component deficiencies; anatomic or functional asplenia; microbiologists routinely exposed to isolates of Neisseria meningitides; and those at increased risk because of a serogroup B meningococcal disease outbreak. This is a category A recommendation. […] Both vaccines have a tendency to cause minor, self-limiting reactions, such as pain at the injection site, fever, headache, fatigue, myalgia, and arthralgia. The incidence of these reactions does not seem to be higher than similar reactions with other vaccines.

• #20 What’s New

  https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Immunization/School/college.aspx

  First-year college students who live in residential housing are recommended to receive MenB if they did not receive a dose on or after their 16th birthday. College students are at increased risk, especially those who are freshmen, attend a four-year university, live in on-campus housing, or participate in sororities and fraternities. […] MenACWY and MenB: Institutions that provide on-campus housing must inform students about meningococcal disease and vaccine. Public institutions must document receipt of information and whether they choose to be immunized (Health and Safety Code, Sections 120395-120399). […] Meningococcal Serogroup B Vaccine (MenB) [optional] MenB vaccine series starting on or after 16th birthday. Students 16 through 23 years of age may receive the vaccine series. CSU System – local requirement at some campuses; check with institution.

• #21 Meningococcal disease | The Australian Immunisation Handbook

  https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/meningococcal-disease

  Any person from 6 weeks of age who wants to reduce their risk of meningococcal disease is recommended to receive MenACWY vaccine and MenB vaccine. […] All infants and children aged <2 years are recommended to receive the MenB vaccine. The MenB vaccine used in infants and children aged <2 years is Bexsero, which is currently the only MenB vaccine registered and available in Australia. [...] Healthy adolescents aged 15–19 years are recommended to receive 2 doses of MenB vaccine. [...] Aboriginal and Torres Strait Islander people aged 2 months to 19 years are recommended to receive a course of MenB vaccine. [...] People with medical conditions that increase their risk of invasive meningococcal disease are recommended to receive MenACWY and MenB vaccines. [...] Laboratory workers who frequently handle Neisseria meningitidis are recommended to receive MenACWY and MenB vaccines. [...] Adolescents and young adults living in close quarters are recommended to receive MenACWY and MenB vaccines. [...] Adolescents and young adults who are current smokers are recommended to receive MenACWY and MenB vaccines.

• #22 Meningococcal group B (MenB) – Public Health Wales

  https://phw.nhs.wales/topics/immunisation-and-vaccines/meningococcal-group-b-menb/

  The MenB vaccine is the safest and most effective way to help protect against meningitis and sepsis caused by meningococcal bacteria group B. […] Babies will normally be given the MenB vaccination as an injection in their upper leg (thigh). Older children and adults will normally receive the MenB vaccination as an injection in their upper arm. […] Since September 2015, babies have been offered the MenB vaccine as part of the routine immunisation schedule in Wales. This is because the MenB vaccine is highly effective against serious infections caused by meningococcal group B bacteria. […] Babies will need three doses of the MenB vaccine to be fully protected. Children who have missed vaccinations and received less than two doses of MenB vaccine in the first year of life should receive further doses before they reach two years of age.

• #23 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Meningococcal vaccine is an active immunizing agent used to prevent infection caused by certain groups of meningococcal bacteria (Neisseria meningitides). The vaccine works by causing your body to produce its own protection (antibodies) against the disease. […] This vaccine is to be given only by or under the supervision of your doctor. […] A nurse or other trained health professional will give this vaccine to you or your child. It is given as a shot under your skin or into one of your muscles. […] Bexsero and Trumenba: An injection is given into a muscle. It is very important for you or your child to receive all of the shots for the vaccine. […] Be sure to notify your doctor of any side effects that occur after you receive this vaccine. […] This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention.

• #24 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Meningococcal vaccine is an active immunizing agent used to prevent infection caused by certain groups of meningococcal bacteria (Neisseria meningitides). The vaccine works by causing your body to produce its own protection (antibodies) against the disease. […] This vaccine is to be given only by or under the supervision of your doctor. […] A nurse or other trained health professional will give this vaccine to you or your child. It is given as a shot under your skin or into one of your muscles. […] Bexsero and Trumenba: An injection is given into a muscle. It is very important for you or your child to receive all of the shots for the vaccine. […] Be sure to notify your doctor of any side effects that occur after you receive this vaccine. […] This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention.

• #25 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] It is important to keep a record of all immunizations received. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] Vaccines are very safe. It is much safer to get the vaccine than to get meningococcal disease.

• #26 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  If a baby is due their MenB vaccine, please ask your pharmacist about paracetamol for them. Fever can be expected after any vaccine but is more common when the MenB vaccine is given with the other routine immunisations at 8 and 16 weeks of age. This is why its recommended that babies gets infant paracetamol when getting these immunisations to prevent and treat fever. […] The MenB vaccine is given as an injection and helps to protect babies against meningitis and septicaemia caused by meningococcal bacteria group B. […] A baby will need 3 doses of the MenB vaccine, one at 8 weeks, one at 16 weeks and one booster dose at 12 to 13 months. […] The vaccine shouldnt be given to babies who have had a severe reaction to a previous dose of the vaccine or any of the ingredients of the vaccine.

• #27 Meningococcal Vaccine Recommendations | Meningococcal | CDC

  https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html

  Both MenB vaccine products require more than 1 dose for maximum protection. Individuals must receive the same vaccine product for all doses. […] CDC recommends a shared clinical decision-making process to decide if MenB vaccination is appropriate for individual adolescents or young adults. […] Administer 2 doses, 6 months apart, to those who want MenB vaccination. […] The preferred age (16 through 18 years) maximizes protection during the ages of highest risk. […] Healthcare providers hopefully will see college-bound adolescents during a pre-college visit. If so, this visit provides an opportunity to initiate the MenB vaccine series for those who choose to receive it. […] People desiring more rapid protection against serogroup B (e.g., students with less than 6 months before college entry) may receive a 3-dose series (0, 12, 6 months) to optimize rapid protection.

• #28 Meningococcal Vaccine Recommendations | Meningococcal | CDC

  https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html

  Both MenB vaccine products require more than 1 dose for maximum protection. Individuals must receive the same vaccine product for all doses. […] CDC recommends a shared clinical decision-making process to decide if MenB vaccination is appropriate for individual adolescents or young adults. […] Administer 2 doses, 6 months apart, to those who want MenB vaccination. […] The preferred age (16 through 18 years) maximizes protection during the ages of highest risk. […] Healthcare providers hopefully will see college-bound adolescents during a pre-college visit. If so, this visit provides an opportunity to initiate the MenB vaccine series for those who choose to receive it. […] People desiring more rapid protection against serogroup B (e.g., students with less than 6 months before college entry) may receive a 3-dose series (0, 12, 6 months) to optimize rapid protection.

• #29 Meningococcal Vaccine Recommendations | Meningococcal | CDC

  https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html

  Both MenB vaccine products require more than 1 dose for maximum protection. Individuals must receive the same vaccine product for all doses. […] CDC recommends a shared clinical decision-making process to decide if MenB vaccination is appropriate for individual adolescents or young adults. […] Administer 2 doses, 6 months apart, to those who want MenB vaccination. […] The preferred age (16 through 18 years) maximizes protection during the ages of highest risk. […] Healthcare providers hopefully will see college-bound adolescents during a pre-college visit. If so, this visit provides an opportunity to initiate the MenB vaccine series for those who choose to receive it. […] People desiring more rapid protection against serogroup B (e.g., students with less than 6 months before college entry) may receive a 3-dose series (0, 12, 6 months) to optimize rapid protection.

• #30 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  The ACIP recommends booster doses for previously vaccinated persons who become or remain at increased risk. For persons 10 years of age or older with persistent complement deficiencies (including patients using a complement inhibitor), anatomic and functional asplenia (including sickle cell disease), or are microbiologists routinely exposed to isolates of N. meningitidis, ACIP recommends single booster dose at 1 yr after completion of primary vaccination and every 2-3 yrs thereafter. […] In October 2024, the ACIP updated their guidance on the dosing of MenB vaccinations. In August, the FDA approved a new dosing schedule for MenB-4C vaccine (Bexsero; GlaxoSmithKline) to include a 3-dose series, previously limited to a 2-dose series. Labeling for MenB-FHbP vaccine (Trumenba) includes both a 2-dose series and a 3-dose series. Thus, the ACIP met to review whether a 3-dose series for Bexsero could align with the recommendations for Trumenba.

• #31 Vaccine Update: ACIP Updates the Immunization Schedule Recommendations for Bexsero (MenB-4C) | Children’s Mercy Kansas City

  https://www.childrensmercy.org/health-care-providers/refer-or-manage-a-patient/connect-with-childrens-mercy/newsletter-the-link/2024/the-link—december-2024/vaccine-update-acip-updates-the-immunization-schedule-recommendations-for-bexsero-menb-4c/

  Bexsero is a vaccine used to prevent invasive disease caused by Neisseria meningitidis serogroup B. Invasive disease from N. meningitidis serogroup B (MenB) can lead to meningitis, sepsis and death. The disease progresses rapidly and, even with appropriate antibiotic therapy, has a case fatality rate of 10%-15%. Approximately 20% of survivors experience long-term sequelae in the form of cognitive deficits, hearing loss, and/or limb amputations. […] For healthy adolescents and young adults aged 16-23 years (preferred 16-18), meningococcal serogroup B vaccination is currently recommended with shared clinical decision-making. […] For persons aged 10 years at increased risk for serogroup B meningococcal disease (i.e., persons with anatomic or functional asplenia, complement component deficiencies, or complement inhibitor use; microbiologists routinely exposed to N. meningitidis isolates; and persons at increased risk during an outbreak). […] For both healthy adolescents and persons at increased risk who were vaccinated at zero and one month or later (old schedule) prior to the new recommendation (Oct. 24, 2024), no additional doses are required. These individuals should continue to get boosters in accordance with prior recommendations.

• #32 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  The ACIP recommends booster doses for previously vaccinated persons who become or remain at increased risk. For persons 10 years of age or older with persistent complement deficiencies (including patients using a complement inhibitor), anatomic and functional asplenia (including sickle cell disease), or are microbiologists routinely exposed to isolates of N. meningitidis, ACIP recommends single booster dose at 1 yr after completion of primary vaccination and every 2-3 yrs thereafter. […] In October 2024, the ACIP updated their guidance on the dosing of MenB vaccinations. In August, the FDA approved a new dosing schedule for MenB-4C vaccine (Bexsero; GlaxoSmithKline) to include a 3-dose series, previously limited to a 2-dose series. Labeling for MenB-FHbP vaccine (Trumenba) includes both a 2-dose series and a 3-dose series. Thus, the ACIP met to review whether a 3-dose series for Bexsero could align with the recommendations for Trumenba.

• #33 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #34 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] It is important to keep a record of all immunizations received. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] Vaccines are very safe. It is much safer to get the vaccine than to get meningococcal disease.

• #35 MenB Vaccine (Meningococcal B Vaccine) | Vaccine Knowledge Project

  https://vaccineknowledge.ox.ac.uk/menb-vaccine

  The vaccine may also contain traces of these products used during the manufacturing process: kanamycin, an antibiotic used in the production process to stop bacteria growing and contaminating the vaccine. […] A new study by Public Health England shows that infant vaccination against MenB has resulted in a significant decline in cases of the disease in young children since the programme was introduced. […] The JCVI have recently suggested that the MenB vaccine should be used in a targeted programme to prevent gonorrhoea.

• #36

  https://www.gov.uk/government/publications/meningococcal-b-vaccine-information-for-healthcare-professionals/meningococcal-b-vaccination-programme-for-infants-information-for-healthcare-practitioners

  This guidance is about the meningococcal B (MenB) vaccination programme for infants. Ensure you use the correct guidance for the programme you are delivering. […] In September 2015, a vaccine against MenB was added to the childhood immunisation programme as part of the routine schedule in England. This document provides further information for healthcare practitioners about the MenB vaccine (Bexsero, also known as 4CMenB) and the MenB vaccination programme offered at 8 and 16 weeks with a booster at 1st birthday. […] The MenB infant programme has reduced the disease in vaccinated cohorts by around 75% when compared with trends in unvaccinated cohorts. The vaccine is effective against MenB IMD in vaccinated individuals but does not protect against carriage of the meningococcus and therefore will not lead to herd protection across the wider population.

• #37

  https://www.gov.uk/government/publications/meningococcal-b-vaccine-information-for-healthcare-professionals/meningococcal-b-vaccination-programme-for-infants-information-for-healthcare-practitioners

  This guidance is about the meningococcal B (MenB) vaccination programme for infants. Ensure you use the correct guidance for the programme you are delivering. […] In September 2015, a vaccine against MenB was added to the childhood immunisation programme as part of the routine schedule in England. This document provides further information for healthcare practitioners about the MenB vaccine (Bexsero, also known as 4CMenB) and the MenB vaccination programme offered at 8 and 16 weeks with a booster at 1st birthday. […] The MenB infant programme has reduced the disease in vaccinated cohorts by around 75% when compared with trends in unvaccinated cohorts. The vaccine is effective against MenB IMD in vaccinated individuals but does not protect against carriage of the meningococcus and therefore will not lead to herd protection across the wider population.

• #38 Meningococcal B

  https://www.hse.ie/eng/health/immunisation/pubinfo/pcischedule/vpds/menb/

  Meningococcal B disease is prevented by vaccination. […] All children are offered MenB vaccine at 2 and 4 months of age with a booster dose of MenB vaccine given at 12 months. […] Children under 1 year of age are most at risk of getting meningococcal B infection and should be vaccinated. […] The MenB vaccine was introduced in Ireland for all children born on or after 1 October 2016 because children under one year are at the highest risk of meningococcal B disease. […] Any child who has missed a dose of MenB vaccine can still get it from their GP up to the age of 2 years. […] Only meningococcal B infection is prevented by the MenB vaccine. Other types of meningococcal infection are not covered by this vaccine. […] After getting the vaccine, your child may have discomfort, redness or swelling around the area where the injection was given. They may be irritable and have a fever. […] Of the children who are immunised: 1 in 2 will have a fever. […] MenB vaccine has been shown to very effective and safe, providing 88% protection against MenB bacteria types.

• #39 CDC Recommendations | TRUMENBA® (Meningococcal Group B Vaccine) | Safety Info

  https://trumenba.pfizerpro.com/about/cdc-recommendations

  CDC recommendations support MenB vaccination for 16-year-olds. […] The preferred age for MenB vaccination is 16 through 18 years. […] The decision to vaccinate should be made based on shared clinical decision-making. […] Individuals at increased risk for MenB should be vaccinated, according to ACIP. […] ACIP recommends certain persons aged 10 years who are at increased risk for meningococcal disease should receive MenB vaccine. […] The American Academy of Pediatrics encourages pediatricians to discuss the availability of MenB vaccines with families, and the decision should be documented if the vaccine is not administered. […] TRUMENBA was the FIRST MenB vaccine with proven protection against diverse strains. […] Trumenba is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age. […] Vaccination with Trumenba may not protect all vaccine recipients against N meningitidis serogroup B infections.

• #40 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Fainting may occur while you are receiving this vaccine. Your doctor may want you to be observed after you get the injection to prevent and manage fainting. […] It is important that your doctor should know about all other vaccines you or your child have recently received, including a flu shot. […] This vaccine may not protect everyone who receives it. It will not treat symptoms of meningococcal infection if you already have the disease.

• #41 MenB Vaccine (Meningococcal B Vaccine) | Vaccine Knowledge Project

  https://vaccineknowledge.ox.ac.uk/menb-vaccine

  The vaccine may also contain traces of these products used during the manufacturing process: kanamycin, an antibiotic used in the production process to stop bacteria growing and contaminating the vaccine. […] A new study by Public Health England shows that infant vaccination against MenB has resulted in a significant decline in cases of the disease in young children since the programme was introduced. […] The JCVI have recently suggested that the MenB vaccine should be used in a targeted programme to prevent gonorrhoea.

• #42 UK vaccine body recommends meningitis B vaccine for gonorrhoea prevention | aidsmap

  https://www.aidsmap.com/news/nov-2023/uk-vaccine-body-recommends-meningitis-b-vaccine-gonorrhoea-prevention

  The JCVI says that although gay and bisexual men should be the primary targets for a vaccine offer, others judged at increased risk of contracting gonorrhoea should also be eligible for the vaccine. […] The JCVI’s decision is based on findings from observational studies in adolescents and young adults in New Zealand, Australia and the United States who received the 4CMenB vaccine to protect against meningitis B. […] The JCVI advice emphasises that the individual reduction in risk may be modest, and that the duration of protection provided by 4CMenB is uncertain. […] Vaccinated individuals could expect to have some reduction in their own risk of contracting gonorrhoea, however the main benefit of a vaccination programme is expected to be at a community level with a significant reduction in the number of cases overall, it says. […] Also, the advice only applies to the vaccine already approved in the UK for meningitis B prevention in adolescents and young people, 4CMenB (Bexsero).

• #43 MenB Vaccine (Meningococcal B Vaccine) | Vaccine Knowledge Project

  https://vaccineknowledge.ox.ac.uk/menb-vaccine

  Meningococcal disease is caused by the bacterium Neisseria meningitidis. It causes a range of serious, life-threatening diseases including septicaemia (blood poisoning) and meningitis (an infection of the protective covering of the brain and spinal cord). […] The MenB vaccine protects against infection by group B meningococcal bacteria. […] In the UK it is recommended that babies receive one dose of the MenB vaccine at 8 weeks, 16 weeks, and one year of age. […] The JCVI also advise that the MenB vaccine should be offered through sexual health services to those who are at increased risk of infection with bacterial sexually transmitted infections. […] Like all vaccines, the MenB vaccine can cause side effects, although not everybody gets them. […] If you are concerned about any reactions that occur after vaccination, consult your doctor.

• #44 MenB Vaccine (Meningococcal B Vaccine) | Vaccine Knowledge Project

  https://vaccineknowledge.ox.ac.uk/menb-vaccine

  Meningococcal disease is caused by the bacterium Neisseria meningitidis. It causes a range of serious, life-threatening diseases including septicaemia (blood poisoning) and meningitis (an infection of the protective covering of the brain and spinal cord). […] The MenB vaccine protects against infection by group B meningococcal bacteria. […] In the UK it is recommended that babies receive one dose of the MenB vaccine at 8 weeks, 16 weeks, and one year of age. […] The JCVI also advise that the MenB vaccine should be offered through sexual health services to those who are at increased risk of infection with bacterial sexually transmitted infections. […] Like all vaccines, the MenB vaccine can cause side effects, although not everybody gets them. […] If you are concerned about any reactions that occur after vaccination, consult your doctor.

• #45 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] It is important to keep a record of all immunizations received. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] Vaccines are very safe. It is much safer to get the vaccine than to get meningococcal disease.

• #46 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #47 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  After having the vaccine there may be side effects, but these are usually mild. […] Vaccines protect babies against the risk of very serious infections and should not be delayed. […] After the MenB vaccine, side effects may include: redness, swelling or tenderness where they had the injection (this will slowly disappear on its own within a few days), being a bit irritable and feeding poorly, sleepiness, a temperature (fever). […] Giving paracetamol will reduce the risk of fever, irritability and discomfort for your baby after immunisation (such as pain at the site of the injection). Ask your pharmacist for infant paracetamol for the MenB vaccine before the babys immunisations are due. […] Its important that a total of 3 doses of infant paracetamol are given to babies when they receive both their first (8 week) and second (16 week) vaccinations.

• #48 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Your health care provider can give you more information. […] Risks of a vaccine reaction […] Soreness, redness, or swelling where the shot is given, tiredness, headache, muscle or joint pain, fever, or nausea can happen after meningococcal B vaccination. […] As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital. […] Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself. […] The National Vaccine Injury Compensation Program (VICP) is a federal program that was created to compensate people who may have been injured by certain vaccines.

• #49

  https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/MenB-Vaccines-What-You-Need-to-Know-VIS.aspx

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Tell your vaccine provider if the person getting the vaccine: Has had an allergic reaction after a previous dose of meningococcal B vaccine, or has any severe, life-threatening allergies. […] In some cases, your health care provider may decide to postpone meningococcal B vaccination to a future visit. […] Your health care provider can give you more information. […] Soreness, redness, or swelling where the shot is given, tiredness, fatigue, headache, muscle or joint pain, fever, chills, nausea, or diarrhea can happen after meningococcal B vaccine.

• #50 Serogroup B Meningococcal Vaccine (MenB)

  https://veteranshealthlibrary.va.gov/MedicationsVA/203,a615045

  Meningococcal B vaccination should be postponed for pregnant people unless the person is at increased risk and, after consultation with their health care provider, the benefits of vaccination are considered to outweigh the potential risks. […] Your health care provider can give you more information. […] Soreness, redness, or swelling where the shot was given, tiredness, headache, muscle or joint pain, fever, or nausea can happen after meningococcal B vaccination. Some of these reactions occur in more than half of the people who receive the vaccine. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.

• #51 Meningococcal Disease and the Men B Vaccine | AAFP

  https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/meningococcal-disease-vaccine.html

  A serogroup B meningococcal (Men B) vaccine series may be administered to adolescents and young adults 16 through 23 years of age to provide short term protection against most strains of serogroup B meningococcal disease. The preferred age for Men B vaccination is 16 through 18 years of age. […] The ACIP recommends routinely administering Men B vaccines among certain individuals 10 years or older who are at increased risk for serogroup B meningococcal disease. This includes those individuals with complement component deficiencies; anatomic or functional asplenia; microbiologists routinely exposed to isolates of Neisseria meningitides; and those at increased risk because of a serogroup B meningococcal disease outbreak. This is a category A recommendation. […] Both vaccines have a tendency to cause minor, self-limiting reactions, such as pain at the injection site, fever, headache, fatigue, myalgia, and arthralgia. The incidence of these reactions does not seem to be higher than similar reactions with other vaccines.

• #52 Meningitis Vaccine Side Effects: What to Know | Bon Secours Blog

  https://blog.bonsecours.com/healthy/meningitis-vaccine-side-effects/

  MenB vaccines are also recommended for teenagers between 16 and 18 years old. […] MenB vaccines can cause these same symptoms as well as fever, chills, nausea and diarrhea. […] Serious reactions are possible, but rare. Additionally, teens are more likely to have side effects after MenB vaccination compared to other vaccines given to preteens and teens.

• #53 Meningococcal group B (MenB) – Public Health Wales

  https://phw.nhs.wales/topics/immunisation-and-vaccines/meningococcal-group-b-menb/

  MenB vaccine is not routinely given to children over two years old unless they are in an at-risk group. […] Vaccination is one of the most effective ways to prevent meningitis and blood poisoning (sepsis) caused by meningitis B infection. No vaccine is 100% effective, so it is still important to know the signs and symptoms of meningitis and sepsis, even if you or your child are vaccinated. […] The most common side effect seen with the MenB vaccine in babies is a fever, or high temperature. Other common side effects of the MenB vaccine include: pain, swelling or redness at the site of the injection; vomiting or diarrhoea (or both); and crying and irritability. […] It is recommended that babies are given infant liquid paracetamol to prevent fever after vaccination. The nurse will give you more information about paracetamol at your vaccination appointment.

• #54 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #55

  https://www.gov.uk/government/publications/meningococcal-b-vaccine-information-for-healthcare-professionals/meningococcal-b-vaccination-programme-for-infants-information-for-healthcare-practitioners

  Infants attending their GP practice for their routine primary immunisations at 8 weeks and 16 weeks of age should be offered meningococcal B vaccine along with their routine infant immunisations, followed by a booster on or after their first birthday. […] Following vaccination, infants may experience symptoms such as fever, irritability and reduced appetite. Infants receiving prophylactic paracetamol when Bexsero is administered with routine immunisations are less likely to experience these symptoms. […] The JCVI has recommended 3 doses of paracetamol to be given to infants receiving Bexsero with their routine primary immunisations at 8 weeks and 16 weeks. Prophylactic paracetamol is not recommended for the 12-month boosters because the infants are older and rates of fever are similar with and without Bexsero administration at this age.

• #56 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  After having the vaccine there may be side effects, but these are usually mild. […] Vaccines protect babies against the risk of very serious infections and should not be delayed. […] After the MenB vaccine, side effects may include: redness, swelling or tenderness where they had the injection (this will slowly disappear on its own within a few days), being a bit irritable and feeding poorly, sleepiness, a temperature (fever). […] Giving paracetamol will reduce the risk of fever, irritability and discomfort for your baby after immunisation (such as pain at the site of the injection). Ask your pharmacist for infant paracetamol for the MenB vaccine before the babys immunisations are due. […] Its important that a total of 3 doses of infant paracetamol are given to babies when they receive both their first (8 week) and second (16 week) vaccinations.

• #57

  https://www.gov.uk/government/publications/meningococcal-b-vaccine-information-for-healthcare-professionals/meningococcal-b-vaccination-programme-for-infants-information-for-healthcare-practitioners

  Infants attending their GP practice for their routine primary immunisations at 8 weeks and 16 weeks of age should be offered meningococcal B vaccine along with their routine infant immunisations, followed by a booster on or after their first birthday. […] Following vaccination, infants may experience symptoms such as fever, irritability and reduced appetite. Infants receiving prophylactic paracetamol when Bexsero is administered with routine immunisations are less likely to experience these symptoms. […] The JCVI has recommended 3 doses of paracetamol to be given to infants receiving Bexsero with their routine primary immunisations at 8 weeks and 16 weeks. Prophylactic paracetamol is not recommended for the 12-month boosters because the infants are older and rates of fever are similar with and without Bexsero administration at this age.

• #58 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #59 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #60

  https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/MenB-Vaccines-What-You-Need-to-Know-VIS.aspx

  An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital. […] Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself.

• #61 Meningococcal Disease and the Men B Vaccine | AAFP

  https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/meningococcal-disease-vaccine.html

  There is a theoretic risk that Men B vaccines could cause autoimmune disease. Both vaccines contain factor H binding protein, which in animal models was noted to be cross-reactive with human factor H. It is not known if auto-antibodies are generated in humans and the clinical significance of any antibodies is unknown. […] FDA approval for the Men B vaccines was granted via an accelerated process, based on 3,000 to 4,000 subjects. Since FDA approval was granted, additional data on more subjects was collected when the vaccines were used during outbreaks on college campuses. […] Additional information was presented in June 2015, to the ACIP including seven creditable, serious adverse events (pyrexia, vomiting, vertigo, chills, headache, anaphylaxis, and neutropenia in 4 out of 9,808 persons who received at least one dose of this vaccine. All adverse effects resolved without long-term consequences.

• #62 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Talk with your health care provider […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. […] Meningococcal B vaccination should be postponed for pregnant women unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks.

• #63

  https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/MenB-Vaccines-What-You-Need-to-Know-VIS.aspx

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Tell your vaccine provider if the person getting the vaccine: Has had an allergic reaction after a previous dose of meningococcal B vaccine, or has any severe, life-threatening allergies. […] In some cases, your health care provider may decide to postpone meningococcal B vaccination to a future visit. […] Your health care provider can give you more information. […] Soreness, redness, or swelling where the shot is given, tiredness, fatigue, headache, muscle or joint pain, fever, chills, nausea, or diarrhea can happen after meningococcal B vaccine.

• #64 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  If a baby is due their MenB vaccine, please ask your pharmacist about paracetamol for them. Fever can be expected after any vaccine but is more common when the MenB vaccine is given with the other routine immunisations at 8 and 16 weeks of age. This is why its recommended that babies gets infant paracetamol when getting these immunisations to prevent and treat fever. […] The MenB vaccine is given as an injection and helps to protect babies against meningitis and septicaemia caused by meningococcal bacteria group B. […] A baby will need 3 doses of the MenB vaccine, one at 8 weeks, one at 16 weeks and one booster dose at 12 to 13 months. […] The vaccine shouldnt be given to babies who have had a severe reaction to a previous dose of the vaccine or any of the ingredients of the vaccine.

• #65 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Talk with your health care provider […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. […] Meningococcal B vaccination should be postponed for pregnant women unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks.

• #66 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://www.healthlinkbc.ca/healthlinkbc-files/meningococcal-b-men-b-vaccine

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] It is important to always report serious or unexpected reactions to your health care provider. […] Speak with your health care provider if you or your child: […] There is no need to delay getting immunized because of a cold or other mild illness. However, if you have concerns speak with your health care provider.

• #67 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  The MenB vaccine helps protect against meningococcal group B bacteria that can cause serious illnesses, including meningitis and sepsis. It’s given to children when they’re 8 weeks, 16 weeks and 1 year old. […] Children are offered 3 doses of the MenB vaccine as part of the NHS vaccination schedule. […] It’s best to have the MenB vaccines on time so children are protected when they’re most at risk of getting MenB illnesses. […] If your child has missed any of their MenB vaccines, contact their GP surgery. They can still have the MenB vaccine up to the age of 2. […] Your child can have the MenB vaccine if they’re unwell but they do not have a high temperature. […] If your child has a high temperature, wait until they’re feeling better before having the vaccine. […] Your GP surgery will usually contact you about your child’s MenB vaccinations.

• #68 Meningococcal B vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007659.htm

  Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. […] Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: […] Talk with your health care provider […] Tell your vaccination provider if the person getting the vaccine: […] In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. […] Meningococcal B vaccination should be postponed for pregnant women unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks.

• #69 Meningococcal Vaccines – Mother To Baby | Fact Sheets – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK582822/

  The Centers for Disease Control and Prevention (CDC) states that MenB vaccines should be postponed in people known to be pregnant unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of getting a vaccine. […] The CDC states that MenB vaccines should be postponed in people known to be breastfeeding unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of vaccination. Be sure to talk to your healthcare provider about all your breastfeeding questions.

• #70 Meningococcal Vaccines – Mother To Baby | Fact Sheets – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK582822/

  The Centers for Disease Control and Prevention (CDC) states that MenB vaccines should be postponed in people known to be pregnant unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of getting a vaccine. […] The CDC states that MenB vaccines should be postponed in people known to be breastfeeding unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of vaccination. Be sure to talk to your healthcare provider about all your breastfeeding questions.

• #71 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://www.healthlinkbc.ca/healthlinkbc-files/meningococcal-b-men-b-vaccine

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] It is important to always report serious or unexpected reactions to your health care provider. […] Speak with your health care provider if you or your child: […] There is no need to delay getting immunized because of a cold or other mild illness. However, if you have concerns speak with your health care provider.

• #72 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  It is important to always report serious or unexpected reactions to your health care provider. […] Speak with your health care provider if you or your child: […] There is no need to delay getting immunized because of a cold or other mild illness. However, if you have concerns speak with your health care provider.

• #73 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Meningococcal vaccine is an active immunizing agent used to prevent infection caused by certain groups of meningococcal bacteria (Neisseria meningitides). The vaccine works by causing your body to produce its own protection (antibodies) against the disease. […] This vaccine is to be given only by or under the supervision of your doctor. […] A nurse or other trained health professional will give this vaccine to you or your child. It is given as a shot under your skin or into one of your muscles. […] Bexsero and Trumenba: An injection is given into a muscle. It is very important for you or your child to receive all of the shots for the vaccine. […] Be sure to notify your doctor of any side effects that occur after you receive this vaccine. […] This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention.

• #74 Meningococcal B Vaccine (4CMenB or MenB-fHBP) – City of Toronto

  https://www.toronto.ca/community-people/health-wellness-care/diseases-medications-vaccines/meningococcal-b-vaccine-4cmenb/

  Meningococcal B vaccine provides protection against disease caused by the B strain. It is given to people who are a close contact of someone with meningococcal B to prevent this serious infection. […] The meningococcal B vaccine is free for close contacts of a confirmed case of meningococcal B infection, and in an outbreak setting. […] The vaccine is also free for children between two months to 17 years of age if they are at higher risk of severe disease, including the following medical conditions: […] Speak to your health care provider if you have questions about getting vaccinated. […] The vaccine is safe, effective and generally well tolerated. […] Please stay at the clinic for 15 minutes following vaccination for staff to monitor for reactions. […] Individuals with a history of anaphylaxis after a previous dose of a 4CMenB or Men B-fHBP vaccine and individuals with proven immediate or anaphylactic hypersensitivity to any component of the vaccine or its container should not receive the vaccine.

• #75 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Fainting may occur while you are receiving this vaccine. Your doctor may want you to be observed after you get the injection to prevent and manage fainting. […] It is important that your doctor should know about all other vaccines you or your child have recently received, including a flu shot. […] This vaccine may not protect everyone who receives it. It will not treat symptoms of meningococcal infection if you already have the disease.

• #76

  https://med.uc.edu/landing-pages/university-health/resources-and-forms/meningococcal-b-disease

  Here at the University of Cincinnati, we care about our students health and a smart choice to make is to get a Meningitis B vaccination. This web page will provide you with general information about meningitis B and the vaccine. […] UCs University Health Services (UHS) Strongly Recommends MenB Vaccine for Students […] Therefore, UCs UHS strongly recommends all students aged 25 and under receive the MenB vaccine. The two-dose vaccine is currently available at our student health center. Getting both shots is important to provide the best protection against this serious disease. […] As with all vaccines, there could be some side effects. The most common include pain at the injection site, painful muscles and joints, nausea, a general feeling of being unwell and a headache. You should contact UHS immediately if any of these become serious or if you notice other side effects. Among young adults, there is also a risk of fainting after getting this, or any, vaccine. We will ask you to stay for 15 minutes after getting the vaccine to ensure that a severe reaction or fainting does not occur.

• #77 Your Child’s Vaccines: Meningococcal Vaccines (for Parents) | Nemours KidsHealth

  https://kidshealth.org/en/parents/meningitis-vaccine.html

  The MenACWY and MenB vaccines can be given at the same time, but at a different place on the body. Also, kids ages 10 or older can get a vaccine that combines MenACWY and MenB in one shot (called MenABCWY) if they’re scheduled to get these vaccines at the same visit. […] Check with your doctor to see if you can give either acetaminophen or ibuprofen for pain or fever and to find out the right dose. […] A warm, damp cloth or a heating pad on the injection site may help reduce soreness, as can moving or using the arm.

• #78 Meningitis B (MenB) vaccine | NHS inform

  https://www.nhsinform.scot/healthy-living/immunisation/vaccines/meningitis-b-menb-vaccine/

  If a baby is due their MenB vaccine, please ask your pharmacist about paracetamol for them. Fever can be expected after any vaccine but is more common when the MenB vaccine is given with the other routine immunisations at 8 and 16 weeks of age. This is why its recommended that babies gets infant paracetamol when getting these immunisations to prevent and treat fever. […] The MenB vaccine is given as an injection and helps to protect babies against meningitis and septicaemia caused by meningococcal bacteria group B. […] A baby will need 3 doses of the MenB vaccine, one at 8 weeks, one at 16 weeks and one booster dose at 12 to 13 months. […] The vaccine shouldnt be given to babies who have had a severe reaction to a previous dose of the vaccine or any of the ingredients of the vaccine.

• #79

  https://www.gov.uk/government/publications/meningococcal-b-vaccine-information-for-healthcare-professionals/meningococcal-b-vaccination-programme-for-infants-information-for-healthcare-practitioners

  Nurses and midwives can only supply or administer medicines using a recognised process. Standards for medicines management that were previously issued by the Nursing and Midwifery Council (NMC) were withdrawn in January 2019 but guidance on where to find further information on the safe and effective handling, management and administration of medicines is available on the NMC website. Nurses should advise parents that they need to ensure that they have liquid paracetamol available for their infant at the time of vaccination and at home for the next 2 days if needed.

• #80 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] It is important to keep a record of all immunizations received. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] Vaccines are very safe. It is much safer to get the vaccine than to get meningococcal disease.

• #81 MenB Information | Student Affairs and Campus Diversity | SDSU

  https://sacd.sdsu.edu/health-promotion/healthier-you/menb

  Fully immunized means having received all doses required for the MenB vaccination, a multi-dose series. […] The best prevention is vaccination. The two vaccines that are most effective against MenB are Bexsero and Trumenba. […] Both MenB vaccines are administered through an intramuscular injection in the arm. […] The Centers for Disease Control and Prevention reports that potential side effects from receiving the MenB vaccine can include soreness, redness and swelling around the area where the shot was given; feeling tired; headaches; muscle or joint pain; fever or chills; nausea or diarrhea. […] If you have started one of the MenB vaccine series (Bexsero or Trumenba), make plans to complete the appropriate series through your health-care provider or a convenient pharmacy at the correct time interval.

• #82 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  It’s best to have the vaccinations on time, but your child can still have the MenB vaccine up to the age of 2. […] Like all medicines, the MenB vaccine can cause side effects, but not all children get them. […] Common side effects of the MenB vaccine include: swelling or pain where the injection was given, a high temperature, feeling tired or irritable, loss of appetite, diarrhoea. […] To help prevent or treat a high temperature, it’s recommended you give your baby child’s paracetamol after their MenB vaccinations at 8 weeks and 16 weeks old. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] The person who vaccinates your child will be trained to deal with allergic reactions and treat them immediately. […] The MenB vaccine works very well at protecting children against most types of meningococcal group B bacteria in the UK. […] Research has shown that the vaccine is very effective at preventing illnesses caused by these bacteria.

• #83 MenB vaccine – NHS

  https://www.nhs.uk/vaccinations/menb-vaccine/

  The MenB vaccine helps protect against meningococcal group B bacteria that can cause serious illnesses, including meningitis and sepsis. It’s given to children when they’re 8 weeks, 16 weeks and 1 year old. […] Children are offered 3 doses of the MenB vaccine as part of the NHS vaccination schedule. […] It’s best to have the MenB vaccines on time so children are protected when they’re most at risk of getting MenB illnesses. […] If your child has missed any of their MenB vaccines, contact their GP surgery. They can still have the MenB vaccine up to the age of 2. […] Your child can have the MenB vaccine if they’re unwell but they do not have a high temperature. […] If your child has a high temperature, wait until they’re feeling better before having the vaccine. […] Your GP surgery will usually contact you about your child’s MenB vaccinations.

• #84 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://www.healthlinkbc.ca/healthlinkbc-files/meningococcal-b-men-b-vaccine

  The Men-B vaccine protects against infection from one of the most common types of meningococcal bacteria, type B. The vaccine is approved by Health Canada. […] In B.C., the Men-B vaccine is provided free to those 2 months of age and older who have been in close contact with a case of meningococcal B disease. […] The vaccine is given by injection as a series of 2, 3 or 4 doses. The number of doses depends on how old you are when the immunization series begins. Speak with your health care provider for more information. […] The vaccine provides long-term protection against meningococcal B infection, a serious and sometimes fatal disease. […] It is important to always report serious or unexpected reactions to your health care provider. […] Speak with your health care provider if you or your child: […] There is no need to delay getting immunized because of a cold or other mild illness. However, if you have concerns speak with your health care provider.

• #85 Meningococcal b (Men-b) vaccine | HealthLink BC

  https://immunizebc.ca/vaccines/meningococcal-b

  It is important to always report serious or unexpected reactions to your health care provider. […] Speak with your health care provider if you or your child: […] There is no need to delay getting immunized because of a cold or other mild illness. However, if you have concerns speak with your health care provider.

• #86

  https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/MenB-Vaccines-What-You-Need-to-Know-VIS.aspx

  An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital. […] Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself.

• #87 ’ + document.title +’

  https://www.lanecounty.org/government/county_departments/health_and_human_services/meningococcal_vaccine_f_a_q

  What are the common side effects? The most common side effects are pain, redness and swelling at the injection site. […] What are the signs of a serious reaction to a vaccine? Severe reactions start a few minutes to a few hours after the vaccination. […] What should I do if I have a serious reaction to the vaccine? Call 911 or go to the nearest hospital if you think you need immediate care.

• #88 Don’t Throw Away Your (MenB) Shot! | Immunize Nevada

  https://immunizenevada.org/news/dont-throw-away-your-menb-shot

  Bottom line, ask your healthcare provider about MenB vaccine if you have a 16-18 year old. […] Bexsero or Trumenba should be available wherever other vaccines are your physicians office, community health clinics, local health districts, retail pharmacies. […] This vaccine is a series, so ask when to return for the next dose. […] With any medicine, including vaccines, there is a chance of side effects. These are usually mild and go away on their own within a few days; serious reactions are rare. […] Here at Immunize Nevada, our mission is to be a trusted resource for immunizations and as part of that, it’s important we help spread awareness about Meningitis B. Parents, young adults, healthcare providers, schools, and universities need to make sure they are educated about all strains of meningitis, including Meningitis B. […] Nevada requires the MenACWY vaccine for 7th grade and university (UNR/UNLV) enrollment, so during that 16 year old appointment for the MenACWY booster dose, ask about the MenB vaccine too.

• #89

  https://varietycare.org/blog/blog-post/variety-care-blog/2021/11/23/protect-their-future-time-to-schedule-your-teenager-s-menb-vaccine

  Youve probably heard of the Meningitis vaccine or the MenACWY vaccine when your child was younger, around 11 or 12. However, that vaccine only protects against bacterial groups A, C, W and Y. The MenB vaccine protects against bacterial group B, and its recommended that teenagers and young adults ages 16 to 23 get this vaccine. […] Your child needs both Meningitis vaccine series to be fully protected against the meningococcal disease. […] Getting vaccinated against Meningitis is the most effective way to prevent meningococcal disease from spreading. This means getting vaccinated with MenACWY at 11 or 12, with a booster at 16 and getting the MenB vaccine between the ages 16 and 23 with a booster a month later. […] As your teenager or young adult prepares for their future, its important for you to take the necessary steps now to protect them.

• #90 Vaccine Update: ACIP Updates the Immunization Schedule Recommendations for Bexsero (MenB-4C) | Children’s Mercy Kansas City

  https://www.childrensmercy.org/health-care-providers/refer-or-manage-a-patient/connect-with-childrens-mercy/newsletter-the-link/2024/the-link—december-2024/vaccine-update-acip-updates-the-immunization-schedule-recommendations-for-bexsero-menb-4c/

  Bexsero is a vaccine used to prevent invasive disease caused by Neisseria meningitidis serogroup B. Invasive disease from N. meningitidis serogroup B (MenB) can lead to meningitis, sepsis and death. The disease progresses rapidly and, even with appropriate antibiotic therapy, has a case fatality rate of 10%-15%. Approximately 20% of survivors experience long-term sequelae in the form of cognitive deficits, hearing loss, and/or limb amputations. […] For healthy adolescents and young adults aged 16-23 years (preferred 16-18), meningococcal serogroup B vaccination is currently recommended with shared clinical decision-making. […] For persons aged 10 years at increased risk for serogroup B meningococcal disease (i.e., persons with anatomic or functional asplenia, complement component deficiencies, or complement inhibitor use; microbiologists routinely exposed to N. meningitidis isolates; and persons at increased risk during an outbreak). […] For both healthy adolescents and persons at increased risk who were vaccinated at zero and one month or later (old schedule) prior to the new recommendation (Oct. 24, 2024), no additional doses are required. These individuals should continue to get boosters in accordance with prior recommendations.

• #91 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  Aetna considers serogroup B meningococcal (MenB) vaccine (Bexsero and Trumenba) as a medically necessary preventive service according to the recommendations of the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). […] ACIP recommends routine vaccination of persons aged 10 years or older at increased risk for meningococcal disease (dosing schedule varies by vaccine brand; boosters should be administered at 1 year after primary series completion, then every 2 – 3 years thereafter). […] MenB vaccination is not routinely recommended for all adolescents. Instead, ACIP recommends a 2-dose MenB series for persons aged 16 to 23 years on the basis of shared clinical decision-making, which refers to an individually based vaccine recommendation informed by a decision-making process between the health care provider and the patient or parent/guardian. The preferred age for MenB vaccination is 16 to 18 years.

• #92 Don’t Throw Away Your (MenB) Shot! | Immunize Nevada

  https://immunizenevada.org/news/dont-throw-away-your-menb-shot

  Bottom line, ask your healthcare provider about MenB vaccine if you have a 16-18 year old. […] Bexsero or Trumenba should be available wherever other vaccines are your physicians office, community health clinics, local health districts, retail pharmacies. […] This vaccine is a series, so ask when to return for the next dose. […] With any medicine, including vaccines, there is a chance of side effects. These are usually mild and go away on their own within a few days; serious reactions are rare. […] Here at Immunize Nevada, our mission is to be a trusted resource for immunizations and as part of that, it’s important we help spread awareness about Meningitis B. Parents, young adults, healthcare providers, schools, and universities need to make sure they are educated about all strains of meningitis, including Meningitis B. […] Nevada requires the MenACWY vaccine for 7th grade and university (UNR/UNLV) enrollment, so during that 16 year old appointment for the MenACWY booster dose, ask about the MenB vaccine too.

• #93 Meningococcal group B (MenB) – Public Health Wales

  https://phw.nhs.wales/topics/immunisation-and-vaccines/meningococcal-group-b-menb/

  MenB vaccine is not routinely given to children over two years old unless they are in an at-risk group. […] Vaccination is one of the most effective ways to prevent meningitis and blood poisoning (sepsis) caused by meningitis B infection. No vaccine is 100% effective, so it is still important to know the signs and symptoms of meningitis and sepsis, even if you or your child are vaccinated. […] The most common side effect seen with the MenB vaccine in babies is a fever, or high temperature. Other common side effects of the MenB vaccine include: pain, swelling or redness at the site of the injection; vomiting or diarrhoea (or both); and crying and irritability. […] It is recommended that babies are given infant liquid paracetamol to prevent fever after vaccination. The nurse will give you more information about paracetamol at your vaccination appointment.

• #94 MenB Information | Student Affairs and Campus Diversity | SDSU

  https://sacd.sdsu.edu/health-promotion/healthier-you/menb

  San Diego State University is continuing its efforts to support the health and safety of the university community. […] SDSU is asking all students 23 years of age and younger to check their immunization records and to get vaccinated for MenB a potentially fatal disease spread through close contact with those who are ill. […] The effective vaccines for MenB are Trumenba and Bexsero, which were approved by the FDA in 2014-15. […] MenB is life-threatening. Prompt diagnosis and treatment is critical because the disease progresses rapidly and can be fatal in as few as 12 hours after symptoms that often resemble influenza. […] All San Diego State University undergraduate students ages 23 and younger who have not been fully immunized with the meningococcal B (MenB) vaccine are urged to get vaccinated as soon as possible.

• #95 Vaccine Update: ACIP Updates the Immunization Schedule Recommendations for Bexsero (MenB-4C) | Children’s Mercy Kansas City

  https://www.childrensmercy.org/health-care-providers/refer-or-manage-a-patient/connect-with-childrens-mercy/newsletter-the-link/2024/the-link—december-2024/vaccine-update-acip-updates-the-immunization-schedule-recommendations-for-bexsero-menb-4c/

  Bexsero is a vaccine used to prevent invasive disease caused by Neisseria meningitidis serogroup B. Invasive disease from N. meningitidis serogroup B (MenB) can lead to meningitis, sepsis and death. The disease progresses rapidly and, even with appropriate antibiotic therapy, has a case fatality rate of 10%-15%. Approximately 20% of survivors experience long-term sequelae in the form of cognitive deficits, hearing loss, and/or limb amputations. […] For healthy adolescents and young adults aged 16-23 years (preferred 16-18), meningococcal serogroup B vaccination is currently recommended with shared clinical decision-making. […] For persons aged 10 years at increased risk for serogroup B meningococcal disease (i.e., persons with anatomic or functional asplenia, complement component deficiencies, or complement inhibitor use; microbiologists routinely exposed to N. meningitidis isolates; and persons at increased risk during an outbreak). […] For both healthy adolescents and persons at increased risk who were vaccinated at zero and one month or later (old schedule) prior to the new recommendation (Oct. 24, 2024), no additional doses are required. These individuals should continue to get boosters in accordance with prior recommendations.

• #96 Meningitis Vaccine | MinuteClinic®

  http://cvs.com/minuteclinic/services/meningitis-vaccine

  MinuteClinic providers are trained to perform immunizations to protect against bacterial meningitis. They can review your medical history and administer the vaccine. Your MinuteClinic provider can help you understand the risks and symptoms of meningitis and advise on prevention. […] Getting the meningococcal vaccine can help protect you from contracting meningitis. […] Serogroup B meningococcal (MenB) vaccines: Teens and young adults (16 to 23 years old): Two doses at least one month apart, ideally between the ages of 16 and 18. […] Adult patients with sickle cell anemia, HIV or persons without a spleen: Two doses at least one month apart, with a booster one year later followed by additional boosters every 2 to 3 years.

• #97 Meningococcal vaccine and haemophilus b vaccine (intramuscular route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-and-haemophilus-b-vaccine-intramuscular-route/description/drg-20075601

  A nurse or other trained health professional will give your child this vaccine. This vaccine is given as a shot into a muscle (usually in the thighs or upper arms). […] It is very important that your child return to your doctors office at the right time for each dose. Be sure to notify your doctor of any side effects that occur after your child receives this vaccine.

• #98 Meningitis B Vaccine Trumenba Injection: Uses & Side Effects

  https://my.clevelandclinic.org/health/drugs/21366-meningococcal-group-b-vaccine-4-strain-suspension-for-injection

  The meningitis B (MenB) vaccine protects you from meningitis B, a potentially fatal disease. The vaccine is approved for use in people 10 to 25 years of age. Speak to a healthcare provider to see if youre eligible for the MenB vaccine. […] This medicine is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting. […] Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 10 years of age for selected conditions, precautions do apply. […] Report any side effects that are worrisome to your doctor right away. […] This vaccine may not protect from all meningitis infections.

• #99 Meningitis B Vaccine Trumenba Injection: Uses & Side Effects

  https://my.clevelandclinic.org/health/drugs/21366-meningococcal-group-b-vaccine-4-strain-suspension-for-injection

  The meningitis B (MenB) vaccine protects you from meningitis B, a potentially fatal disease. The vaccine is approved for use in people 10 to 25 years of age. Speak to a healthcare provider to see if youre eligible for the MenB vaccine. […] This medicine is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting. […] Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 10 years of age for selected conditions, precautions do apply. […] Report any side effects that are worrisome to your doctor right away. […] This vaccine may not protect from all meningitis infections.

• #100 Your Child’s Vaccines: Meningococcal Vaccines (for Parents) | Nemours KidsHealth

  https://kidshealth.org/en/parents/meningitis-vaccine.html

  The MenACWY and MenB vaccines can be given at the same time, but at a different place on the body. Also, kids ages 10 or older can get a vaccine that combines MenACWY and MenB in one shot (called MenABCWY) if they’re scheduled to get these vaccines at the same visit. […] Check with your doctor to see if you can give either acetaminophen or ibuprofen for pain or fever and to find out the right dose. […] A warm, damp cloth or a heating pad on the injection site may help reduce soreness, as can moving or using the arm.

• #101 Meningococcal vaccine (intramuscular route, subcutaneous route) – Mayo Clinic

  https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-intramuscular-route-subcutaneous-route/description/drg-20064657

  Fainting may occur while you are receiving this vaccine. Your doctor may want you to be observed after you get the injection to prevent and manage fainting. […] It is important that your doctor should know about all other vaccines you or your child have recently received, including a flu shot. […] This vaccine may not protect everyone who receives it. It will not treat symptoms of meningococcal infection if you already have the disease.

• #102 Meningococcal Vaccines for Children: Care Instructions | Kaiser Permanente

  https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.meningococcal-vaccines-for-children-care-instructions.abo1387

  The MenB vaccine protects against one common strain. This is recommended only for certain people. […] The MenB vaccine is recommended for certain people who got the MenACWY vaccine. College students who plan to live in dormitories are one group that might want to get it. Your doctor may also recommend it if your child has certain health problems or takes certain medicines. […] Follow-up care is a key part of your child’s treatment and safety. Be sure to make and go to all appointments, and call your doctor if your child is having problems. It’s also a good idea to know your child’s test results and keep a list of the medicines your child takes.

• #103 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  The ACIP recommends booster doses for previously vaccinated persons who become or remain at increased risk. For persons 10 years of age or older with persistent complement deficiencies (including patients using a complement inhibitor), anatomic and functional asplenia (including sickle cell disease), or are microbiologists routinely exposed to isolates of N. meningitidis, ACIP recommends single booster dose at 1 yr after completion of primary vaccination and every 2-3 yrs thereafter. […] In October 2024, the ACIP updated their guidance on the dosing of MenB vaccinations. In August, the FDA approved a new dosing schedule for MenB-4C vaccine (Bexsero; GlaxoSmithKline) to include a 3-dose series, previously limited to a 2-dose series. Labeling for MenB-FHbP vaccine (Trumenba) includes both a 2-dose series and a 3-dose series. Thus, the ACIP met to review whether a 3-dose series for Bexsero could align with the recommendations for Trumenba.

• #104 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  Pregnant and lactating women should receive MenACWY vaccine if indicated. Because limited data are available for MenB vaccination during pregnancy, vaccination with MenB should be deferred unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks. […] Persons with functional or anatomic asplenia (including sickle cell disease) and persistent complement component deficiency (including persons taking eculizumab [Soliris]) are at increased risk for meningococcal disease and should receive both MenACWY and MenB vaccines.

• #105 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  Pregnant and lactating women should receive MenACWY vaccine if indicated. Because limited data are available for MenB vaccination during pregnancy, vaccination with MenB should be deferred unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks. […] Persons with functional or anatomic asplenia (including sickle cell disease) and persistent complement component deficiency (including persons taking eculizumab [Soliris]) are at increased risk for meningococcal disease and should receive both MenACWY and MenB vaccines.

• #106 Meningococcal Vaccines – Mother To Baby | Fact Sheets – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK582822/

  The Centers for Disease Control and Prevention (CDC) states that MenB vaccines should be postponed in people known to be pregnant unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of getting a vaccine. […] The CDC states that MenB vaccines should be postponed in people known to be breastfeeding unless they are at increased risk for serogroup B meningococcal disease. Your healthcare providers can talk with you about your risk for meningococcal disease and the benefits of vaccination. Be sure to talk to your healthcare provider about all your breastfeeding questions.

• #107 Meningococcal Vaccines – Medical Clinical Policy Bulletins | Aetna

  https://www.aetna.com/cpb/medical/data/300_399/0356.html

  Pregnant and lactating women should receive MenACWY vaccine if indicated. Because limited data are available for MenB vaccination during pregnancy, vaccination with MenB should be deferred unless the woman is at increased risk and, after consultation with her health care provider, the benefits of vaccination are considered to outweigh the potential risks. […] Persons with functional or anatomic asplenia (including sickle cell disease) and persistent complement component deficiency (including persons taking eculizumab [Soliris]) are at increased risk for meningococcal disease and should receive both MenACWY and MenB vaccines.

• #108 What’s New

  https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Immunization/School/college.aspx

  First-year college students who live in residential housing are recommended to receive MenB if they did not receive a dose on or after their 16th birthday. College students are at increased risk, especially those who are freshmen, attend a four-year university, live in on-campus housing, or participate in sororities and fraternities. […] MenACWY and MenB: Institutions that provide on-campus housing must inform students about meningococcal disease and vaccine. Public institutions must document receipt of information and whether they choose to be immunized (Health and Safety Code, Sections 120395-120399). […] Meningococcal Serogroup B Vaccine (MenB) [optional] MenB vaccine series starting on or after 16th birthday. Students 16 through 23 years of age may receive the vaccine series. CSU System – local requirement at some campuses; check with institution.

• #109 What’s New

  https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Immunization/School/college.aspx

  First-year college students who live in residential housing are recommended to receive MenB if they did not receive a dose on or after their 16th birthday. College students are at increased risk, especially those who are freshmen, attend a four-year university, live in on-campus housing, or participate in sororities and fraternities. […] MenACWY and MenB: Institutions that provide on-campus housing must inform students about meningococcal disease and vaccine. Public institutions must document receipt of information and whether they choose to be immunized (Health and Safety Code, Sections 120395-120399). […] Meningococcal Serogroup B Vaccine (MenB) [optional] MenB vaccine series starting on or after 16th birthday. Students 16 through 23 years of age may receive the vaccine series. CSU System – local requirement at some campuses; check with institution.

• #110 Meningococcal Disease and the Vaccine: What College Students Need to Know – MN Dept. of Health

  https://www.health.state.mn.us/diseases/meningococcal/collegefact.html

  Anyone can get meningococcal disease, but first-year college students who live in dormitories or participate in sororities or fraternities are at increased risk and should get vaccinated. […] The MenB vaccine is not routinely recommended for college students. However, some colleges and universities require MenB vaccination for incoming students. While small outbreaks of meningococcal serogroup B disease have occurred on college campuses, the disease incidence in college students remains very low. It is important for students ages 16 to 23 who are planning to go to college or currently in college, to have a conversation with their health care provider about receiving the MenB vaccine. Anyone who has been fully vaccinated against MenB, would only need a single booster dose in the case of an outbreak on campus.

• #111 Meningococcal Disease and the Vaccine: What College Students Need to Know – MN Dept. of Health

  https://www.health.state.mn.us/diseases/meningococcal/collegefact.html

  Anyone can get meningococcal disease, but first-year college students who live in dormitories or participate in sororities or fraternities are at increased risk and should get vaccinated. […] The MenB vaccine is not routinely recommended for college students. However, some colleges and universities require MenB vaccination for incoming students. While small outbreaks of meningococcal serogroup B disease have occurred on college campuses, the disease incidence in college students remains very low. It is important for students ages 16 to 23 who are planning to go to college or currently in college, to have a conversation with their health care provider about receiving the MenB vaccine. Anyone who has been fully vaccinated against MenB, would only need a single booster dose in the case of an outbreak on campus.

Zobacz więcej